Show simple item record

dc.contributor.authorCanal-Sotelo, Jaume
dc.contributor.authorTrujillano Cabello, Javier
dc.contributor.authorLarkin, Philip
dc.contributor.authorArraràs-Torrelles, Núria
dc.contributor.authorGonzález-Rubió, Ramona
dc.contributor.authorRocaspana-Garcia, Mariona
dc.contributor.authorBarallat Gimeno, Eva
dc.description.abstractBackground Breakthrough cancer pain (BTcP) is defined according to its principal characteristics: high intensity, short time interval between onset and peak intensity, short duration, potential recurrence over 24 h and non-responsiveness to standard analgesic regimes. The Edmonton Classification System for Cancer Pain (ECS-CP) is a classification tool that evaluates different dimensions of pain. The aim of this study was to measure prevalence and the main characteristics of BTcP in a sample of advanced cancer patients and to explore the complexity observed when ECS-CP is incorporated into BTcP diagnostics algorithm. Methods Descriptive prevalence study (Retrospective chart review). Davies' algorithm was used to identify BTcP and ECS-CP was used to recognize appropriate dimensions of pain. The study was conducted in a sample of advanced cancer patients attending hospital outpatient clinic in Lleida, Spain. 277 patients were included from 01/01/2014 to 31/12/2015. No direct contact was made with participants. The following information was extracted from the palliative care outpatient clinic database: age, gender, civil status, cognitive impairment status, functional performance status and variables related to tumour. Only BTcP cases were included. Results Prevalence of BTcP was 39.34% (63.9% men). Mean of age was 68.2 years. Main diagnosis was lung cancer (n = 154; 31.6%). Metastases were diagnosed in 83% of the sample. 138 patients (49.8%) were diagnosed with 1 type of BTcP and 139 (50.2%) were diagnosed with more than one type of BTcP. In total, 488 different types of BTcP were recorded (mean 1.75 ± 0, 9), 244 of these types (50%) presented a component of neuropathic pain. Addictive behaviour, measured through CAGE test, was present in 29.2% (N = 81) of the patients and psychological distress was present in 40.8% (n = 113). Conclusions Prevalence of BTcP (39.34%) is similar to the one reflected in the existing literature. Study results indicate that the routine use of ECS-CP in a clinical setting allows us to detect more than one type of BTcP as well as additional complexity associated with pain (neuropathic, addictive behavior and psychological distress). Keywords Breakthrough cancer painPalliative careECS-CPNeuropathic painAddictive behaviourPsychological distress
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofBMC Palliative Care, 2018, vol. 17, núm. 81
dc.rightscc-by (c) Canal-Sotelo, Jaume et al., 2018
dc.subjectBreakthrough cancer pain
dc.subjectpalliative care
dc.subjectneuropathic pain
dc.subjectAddictive behaviour
dc.titlePrevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm

Files in this item


This item appears in the following Collection(s)

Show simple item record

cc-by (c) Canal-Sotelo, Jaume et al., 2018
Except where otherwise noted, this item's license is described as cc-by (c) Canal-Sotelo, Jaume et al., 2018